Baton Rouge, Louisiana
Esperance Pharmaceuticals, Inc. is developing a new class of targeted anti-cancer drugs that selectively kill cancer cells without harming normal cells. Targeting occurs through binding to specific receptors on the cell’s surface.
View Website